| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.097 | 0.07 |